Market Research Future (MRFR) announces the publication of its research report – Global Facial Paralysis Market, 2018–2023
Market Highlights
Facial paralysis is a restriction of the facial movement due to nerve damage. Facial nerve paralysis is characterized by unilateral facial weakness. Some other symptoms include loss of taste, hyperacusis, and decreased salivation and tear secretion.
The global facial paralysis market is expected to register a CAGR of 6.5% during the forecast period.
get sample @ https://www.marketresearchfuture.com/sample_request/5942
Factors that are likely to hamper the growth of the market are product failures and recalls.
Global Facial Paralysis market is expected to grow at a CAGR of 6.5% during the forecast period.
Segments
The global facial paralysis market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into bell’s palsy, Ramsay Hunt syndrome, and Lyme disease.
On the basis of diagnosis, the market is segmented into electromyography, computerized tomography, and magnetic resonance imaging.
On the basis of treatment, the market is segmented into medications, physical therapy,
On the basis of medications, the market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is segmented into hospitals and clinics, specialty centers, and research centers.
Key Players
Some of the key players in the Facial Paralysis Treatment Market are Boston Scientific, BioControl Medical, Cerebomed, Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis AG, among others.
READ MORE @ https://www.marketresearchfuture.com/reports/facial-paralysis-market-5942
Related Reports
RELATED REPORTS
Vertigo Treatment Market Research Report - Global Forecast till 2027
Pain Relief Medication Market Research Report - Global Forecast till 2027
Orthopedic Braces Market Research Report - Global Forecast till 2027
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
According to research report the interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.
Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548Interventional cardiology devices are devices that are used to unclog blood vessels and restore normal blood flow.
The market for these devices is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5% during the forecast period.
Growth in this market is mainly driven by factors such as the rapidly increasing geriatric population and technological advancements in interventional cardiology devices.The interventional cardiology devices market is geographically segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
Asia Pacific is expected to register the highest growth due to the improving healthcare infrastructure, the heavy burden of cardiovascular diseases, rising healthcare expenditure, and growth in the demand for interventional cardiology devices.On the basis of type, the interventional cardiology devices market is categorized into angioplasty balloons, angioplasty stents, catheters, plaque modification devices, hemodynamic flow alteration devices, and other interventional cardiology devices.
Growth in this market is mainly due to the increasing adoption of these devices for plaque removal in arteries due to their effectiveness.The angioplasty stents market is further segmented into bare-metal stents, drug-eluting stents, and bioresorbable stents.
